CVS HEALTH CORP (CVS) Stock Institutional Trading Activity


CVS HEALTH CORP (CVS) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Hancock Classic Value, Ariel Appreciation Fund, Olstein Capital Management, Cullen Value Fund, and Tweedy, Browne Co All Funds (US). Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2019Dodge & Cox Stock FundSell-357,60120,495,571$1,522,616
Q4 2019Parnassus Endeavor FundBuy111,5388,372,832$622,017
Q4 2019Sequoia Financial AdvisorsBuy6624,733$352
Q4 2019Renaissance Technologies LLCSell-386,21513,053$970
Q4 2019Fairfax Financial HoldingsBuy26,50026,500$1,968
Q4 2019Hillman Value FundBuy71,20671,206$5,290
Q4 2019Muhlenkamp & CoBuy36,479106,514$7,913
Q4 2019Matrix Advisors Value FundBuy22,178300,087$22,293
Q4 2019Miller Value PartnersSell-350759,225$56,403
Q4 2019Hancock Classic ValueSell-132951,790$70,708
Q3 2019Olstein Capital ManagementBuy3,300186,300$11,750
Q3 2019Dodge & Cox Stock FundBuy162,86820,853,172$1,315,210
Q3 2019Parnassus Endeavor FundBuy1,020,9048,261,294$521,040
Q3 2019Sequoia Financial AdvisorsSell-1,4704,071$257
Q3 2019Muhlenkamp & CoBuy70,03570,035$4,417
Q3 2019Matrix Advisors Value FundBuy27,742277,909$17,528
Q3 2019Renaissance Technologies LLCBuy196,615399,268$25,182
Q3 2019Vulcan Value PartnersSell-171,7198,754,912$552,172
Q3 2019Hancock Classic ValueBuy236,189951,922$60,038
Q2 2019Olstein Capital ManagementBuy6,000183,000$9,972
Q2 2019Dodge & Cox Stock FundBuy842,14020,690,304$1,127,415
Q2 2019Parnassus Endeavor FundSell-4,399,0397,240,390$394,529
Q2 2019Sequoia Financial AdvisorsSell-2,1405,541$302
Q2 2019Renaissance Technologies LLCSell-100,900202,653$11,043
Q2 2019Matrix Advisors Value FundBuy41,479250,167$13,632
Q2 2019Miller Value PartnersBuy759,575759,575$41,389
Q2 2019Vulcan Value PartnersBuy968,1628,926,631$486,412
Q2 2019Hancock Classic ValueSell-3,151715,733$39,000
Q1 2019Olstein Capital ManagementBuy50,000177,000$9,546
Q1 2019Dodge & Cox Stock FundBuy3,799,27519,848,164$1,070,411

Frequently asked questions about CVS activity

  • Which institutional owners are buying CVS?

    Institutional owners buying CVS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in CVS activity?

    "Buy" means an investor increased their reported position in CVS compared to the prior reporting period. This reflects growing exposure to CVS HEALTH CORP (CVS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in CVS increasing?

    Institutional interest in CVS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.